$NVCR NovoCure Ltd Insider Trading Week 46/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd in week 46/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 20,000 | 140,600 | 39,214 | |
| Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 90.00 | 20,000 | 1,800,000 | 69,504 | 89.5 K to 69.5 K (-22.35 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 20,000 | 140,600 | 89,504 | 69.5 K to 89.5 K (+28.78 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 91.01 | 700 | 63,707 | 659,465 | 660.2 K to 659.5 K (-0.11 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 90.36 | 149,300 | 13,490,016 | 660,165 | 809.5 K to 660.2 K (-18.44 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 10,000 | 70,300 | 59,214 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 5,257 | 36,957 | 69,214 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 4,743 | 16,316 | 0 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 85.00 | 10,000 | 850,000 | 69,504 | 79.5 K to 69.5 K (-12.58 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 10,000 | 70,300 | 79,504 | 69.5 K to 79.5 K (+14.39 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 84.00 | 354 | 29,737 | 69,504 | 69.9 K to 69.5 K (-0.51 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 83.51 | 3,203 | 267,486 | 69,858 | 73.1 K to 69.9 K (-4.38 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 82.52 | 1,700 | 140,282 | 73,061 | 74.8 K to 73.1 K (-2.27 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 5,257 | 36,957 | 74,761 | 69.5 K to 74.8 K (+7.56 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 84.02 | 443 | 37,220 | 69,504 | 69.9 K to 69.5 K (-0.63 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 83.50 | 2,800 | 233,803 | 69,947 | 72.7 K to 69.9 K (-3.85 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 82.55 | 1,500 | 123,825 | 72,747 | 74.2 K to 72.7 K (-2.02 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 4,743 | 16,316 | 74,247 | 69.5 K to 74.2 K (+6.82 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 5,832 | 20,062 | 0 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 5,832 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 86.93 | 900 | 78,234 | 87,179 | 88.1 K to 87.2 K (-1.02 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 86.08 | 3,132 | 269,603 | 88,079 | 91.2 K to 88.1 K (-3.43 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 85.35 | 1,800 | 153,634 | 91,211 | 93 K to 91.2 K (-1.94 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 5,832 | 20,062 | 93,011 | 87.2 K to 93 K (+6.69 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 84.01 | 1,439 | 120,886 | 87,179 | 88.6 K to 87.2 K (-1.62 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 83.52 | 12,461 | 1,040,768 | 88,618 | 101.1 K to 88.6 K (-12.33 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.53 | 6,100 | 503,439 | 101,079 | 107.2 K to 101.1 K (-5.69 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |